Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Krka is a leading international generic pharmaceutical company headquartered in Slovenia, specializing in the development and production of high-quality prescription and non-prescription medicines. The company's primary therapeutic focus spans cardiovascular diseases, gastrointestinal tract disorders, and central nervous system conditions, complemented by a robust animal health portfolio. Krka employs a vertically integrated business model, overseeing the entire lifecycle of its products from the synthesis of active pharmaceutical ingredients to the manufacturing of finished dosage forms. With a presence in over 70 markets, the company is recognized for its extensive R&D capabilities and commitment to providing affordable healthcare solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Krka-Farma.